Efalizumab discontinuation: a practical strategy. [electronic resource]
Producer: 20090813Description: 132-6 p. digitalISSN:- 1471-1753
- Adverse Drug Reaction Reporting Systems
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Canada
- Drug and Narcotic Control
- Drug-Related Side Effects and Adverse Reactions
- Europe
- Female
- Humans
- Leukoencephalopathy, Progressive Multifocal -- chemically induced
- Male
- Psoriasis -- drug therapy
- Risk Assessment
- United States
- Withholding Treatment
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.